What was Qrons’s price range in the past 12 months?
Qrons lowest stock price was $0.01 and its highest was $0.02 in the past 12 months.
What is Qrons’s market cap?
Qrons’s market cap is $198.86K.
When is Qrons’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Qrons overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Qrons pay dividends?
Qrons does not currently pay dividends.
What is Qrons’s EPS estimate?
Qrons’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Qrons have?
Qrons has 17,914,999 shares outstanding.
Which hedge fund is a major shareholder of Qrons?
Currently, no hedge funds are holding shares in QRON
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Qrons
Qrons, Inc. is a biotechnology company, which engages in the development of treatments and technologies for neuronal and infectious diseases. Its proprietary patents include Techniques for Promoting Neuronal Recovery, Therapeutic Polypseudorotaxane Hydrogels, and Tellurium Compositions and Techniques for Use Therewith. The company was founded by Jonah Martin Meer and Ido Merfeld on August 22, 2016 and is headquartered in Glendale, CA.